PL366705A1 - Interferon gamma polypeptide variants - Google Patents

Interferon gamma polypeptide variants

Info

Publication number: PL366705A1
Authority: PL; Poland
Prior art keywords: interferon gamma; polypeptide variants; gamma polypeptide; variants; interferon
Prior art date: 2001-04-06

Application number

PL02366705A

Other languages

Polish (pl)

Inventor

Anne Dam Jensen

Original Assignee

Maxygen Holdings Ltd.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-06

Filing date

2002-04-04

Publication date

2005-02-07

2002-04-04 Application filed by Maxygen Holdings Ltd. filed Critical Maxygen Holdings Ltd.

2005-02-07 Publication of PL366705A1 publication Critical patent/PL366705A1/en

Links

102000008070 Interferon-gamma Human genes 0.000 title 1
108010074328 Interferon-gamma Proteins 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/57—IFN-gamma
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Toxicology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicinal Preparation (AREA)

PL02366705A 2001-04-06 2002-04-04 Interferon gamma polypeptide variants PL366705A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DKPA200100579		2001-04-06
DKPA200100714		2001-05-07
DKPA200200198		2002-02-11

Publications (1)

Publication Number	Publication Date
PL366705A1 true PL366705A1 (en)	2005-02-07

Family

ID=27222504

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL02366705A PL366705A1 (en)	2001-04-06	2002-04-04	Interferon gamma polypeptide variants

Country Status (14)

Country	Link
EP (1)	EP1412382A2 (en)
JP (1)	JP2005518183A (en)
KR (1)	KR20030094336A (en)
CN (1)	CN1257186C (en)
BG (1)	BG108256A (en)
BR (1)	BR0208596A (en)
CA (1)	CA2443277A1 (en)
HU (1)	HUP0303645A3 (en)
IL (1)	IL157896A0 (en)
MX (1)	MXPA03009082A (en)
NO (1)	NO20034432L (en)
NZ (1)	NZ528651A (en)
PL (1)	PL366705A1 (en)
WO (1)	WO2002081507A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2525647A1 (en)	2003-05-16	2005-02-24	Intermune, Inc.	Synthetic chemokine receptor ligands and methods of use thereof
JP4707327B2 (en) *	2004-01-27	2011-06-22	旭化成ファーマ株式会社	Polypeptides adsorption inhibitors
MX2007001589A (en) *	2004-08-09	2007-08-02	Alios Biopharma Inc	Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same.
US7597884B2 (en)	2004-08-09	2009-10-06	Alios Biopharma, Inc.	Hyperglycosylated polypeptide variants and methods of use
CN103550757A (en) *	2005-09-20	2014-02-05	纽约大学	Method for treating lung diseases by using interferon
US7625555B2 (en)	2007-06-18	2009-12-01	Novagen Holding Corporation	Recombinant human interferon-like proteins
JP5769142B2 (en) *	2007-09-04	2015-08-26	独立行政法人酒類総合研究所	Method for high secretion of heterologous proteins in Pichia yeast
EP2039764A1 (en) *	2007-09-19	2009-03-25	Pevion Biotech AG	Truncated secretory aspartyl proteinase 2
BG66517B1 (en)	2008-04-08	2016-02-29	Tigo Gmbh	Inhibitor of endogenous human interferon - gamma
RU2446821C2 (en) *	2010-07-15	2012-04-10	Олег Ильич Эпштейн	Drug preparation for treating infectious diseases accompanied by neurotoxic disorders, and method of treating infectious diseases accompanied by neurotoxic disorders
GB201621728D0 (en)	2016-12-20	2017-02-01	Ucb Biopharma Sprl	Methods
BG67190B1 (en)	2017-03-29	2020-11-16	Tigo Gmbh	Anti-gama mutant protein against endogenous human gamma interferon
CN118974079A (en) *	2022-03-22	2024-11-15	清迈大学	Modified interferon gamma protein and its use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX9203641A (en) *	1983-12-16	1992-07-01	Genentech Inc	RECOMBINANT GAMMA INTERFERONS THAT HAVE IMPROVED STABILITY AND BIOTECHNOLOGICAL METHODS FOR THEIR OBTAINING.
BG52073B2 (en) *	1990-01-24	1996-04-30	Inst Molekuljarna Biolog	Method for the preparation of recombinant human noncystein -interferon, free of n-end methionine
DE4036856C1 (en) *	1990-11-19	1992-05-27	Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung Ev, 8000 Muenchen, De

2002
- 2002-04-04 PL PL02366705A patent/PL366705A1/en not_active Application Discontinuation
- 2002-04-04 JP JP2002579493A patent/JP2005518183A/en active Pending
- 2002-04-04 CA CA002443277A patent/CA2443277A1/en not_active Abandoned
- 2002-04-04 NZ NZ528651A patent/NZ528651A/en unknown
- 2002-04-04 MX MXPA03009082A patent/MXPA03009082A/en not_active Application Discontinuation
- 2002-04-04 EP EP02722021A patent/EP1412382A2/en not_active Withdrawn
- 2002-04-04 IL IL15789602A patent/IL157896A0/en unknown
- 2002-04-04 KR KR10-2003-7013263A patent/KR20030094336A/en not_active Ceased
- 2002-04-04 CN CNB028078918A patent/CN1257186C/en not_active Expired - Fee Related
- 2002-04-04 HU HU0303645A patent/HUP0303645A3/en unknown
- 2002-04-04 WO PCT/DK2002/000226 patent/WO2002081507A2/en not_active Ceased
- 2002-04-04 BR BR0208596-8A patent/BR0208596A/en not_active IP Right Cessation
2003
- 2003-10-03 NO NO20034432A patent/NO20034432L/en not_active Application Discontinuation
- 2003-10-10 BG BG108256A patent/BG108256A/en unknown

Also Published As

Publication number	Publication date
KR20030094336A (en)	2003-12-11
NO20034432D0 (en)	2003-10-03
HUP0303645A2 (en)	2004-01-28
NZ528651A (en)	2006-06-30
IL157896A0 (en)	2004-03-28
WO2002081507A3 (en)	2004-02-12
CA2443277A1 (en)	2002-10-17
CN1257186C (en)	2006-05-24
HK1069834A1 (en)	2005-06-03
NO20034432L (en)	2003-10-29
BR0208596A (en)	2004-03-09
BG108256A (en)	2004-12-30
WO2002081507A2 (en)	2002-10-17
JP2005518183A (en)	2005-06-23
MXPA03009082A (en)	2004-11-22
EP1412382A2 (en)	2004-04-28
CN1537117A (en)	2004-10-13
HUP0303645A3 (en)	2005-12-28

Legal Events

Date	Code	Title	Description
2011-02-28	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
AU2002367859A8 (en)	2003-12-02	Polypeptide immobilization
IL157896A0 (en)	2004-03-28	Interferon gamma polypeptide variants
PL375218A1 (en)	2005-11-28	Recombinant protein variants
PL373008A1 (en)	2005-08-08	Cytokine polypeptides
GB0100196D0 (en)	2001-02-14	Peptides
GB0201679D0 (en)	2002-03-13	Polypeptide variants
GB0218977D0 (en)	2002-09-25	Polypeptide
GB0109438D0 (en)	2001-06-06	Peptides
DE50214962D1 (en)	2011-04-28	Heterocyclylarylsulfonamide
GB0112342D0 (en)	2001-07-11	Polypeptides
GB0223193D0 (en)	2002-11-13	Polypeptide
GB0103517D0 (en)	2001-03-28	Polypeptide
PL375202A1 (en)	2005-11-28	Cytokine polypeptides
GB0208925D0 (en)	2002-05-29	Polypeptide
GB0101739D0 (en)	2001-03-07	Novel polypeptide
EP1373306A4 (en)	2005-07-20	Cytoskeletion-associated proteins
EP1477559A4 (en)	2005-12-07	NEW POLYPEPTIDE
GB0100039D0 (en)	2001-02-14	Novel polypeptide
GB0104118D0 (en)	2001-04-11	Novel polypeptide
GB0101222D0 (en)	2001-02-28	Novel polypeptide
GB0111031D0 (en)	2001-06-27	Novel polypeptide
GB0107394D0 (en)	2001-05-16	Novel polypeptide
EP1362865A4 (en)	2004-05-06	Cyclic peptide
GB0108218D0 (en)	2001-05-23	New polypeptide
AU2002326909A8 (en)	2006-11-02	Neurotransmission-associated proteins